In our study, a comparison between the pre-COVID-19 pandemic and during the COVID-19 pandemic found a significant difference in pneumonia as a DKA precipitant, but there was no statistically significant difference in DKA severity, or DKA outcomes (mortality, units of insulin used, length of hospital stay and time to DKA resolution). Here, INS is linked to susceptibility to pneumonia measurement.